HMDCF OTC
HUTCHMED (China) Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -41.0%
1Y: -32.5%
3Y: -31.4%
5Y: -57.7%
$2.16
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$549M
-12.8% ▼
5Y CAGR: +19.2%
Gross Profit
$212M
-24.5% ▼
5Y CAGR: +40.0%
Operating Income
-$55M
-34.6% ▼
Net Income
$458M
+1112.8% ▲
EPS (Diluted)
$0.52
+1103.7% ▲
EBITDA
-$41M
-391.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $356M | $426M | $838M | $630M | $549M |
| YoY Growth | +56.2% | +19.7% | +96.5% | -24.8% | -12.8% |
| Cost of Revenue | $258M | $311M | $384M | $349M | $337M |
| Gross Profit | $98M | $115M | $454M | $281M | $212M |
| Gross Margin | 27.5% | 27.0% | 54.1% | 44.6% | 38.7% |
| R&D Expenses | $315M | $391M | $302M | $212M | $164M |
| SG&A Expenses | $127M | $136M | $133M | $113M | $103M |
| Operating Expenses | $426M | $523M | $432M | $322M | $267M |
| Operating Income | -$343M | -$413M | $18M | -$41M | -$55M |
| Operating Margin | -96.2% | -96.9% | 2.2% | -6.4% | -10.0% |
| Interest Expense | $592K | $652K | $759K | $3M | $3M |
| Income Before Tax | -$155M | -$362M | $106M | $45M | $522M |
| Tax Expense | $12M | -$283K | $5M | $7M | $64M |
| Net Income | -$195M | -$361M | $101M | $38M | $458M |
| Net Margin | -54.7% | -84.6% | 12.0% | 6.0% | 83.3% |
| EPS (Diluted) | $-0.24 | $-0.43 | $0.12 | $0.04 | $0.52 |
| EBITDA | -$207M | -$402M | $67M | $14M | -$41M |
| Shares Outstanding | 793M | 847M | 869M | 873M | 873M |